FREDERICK, Md. (April 11, 2025) Researchers with Naval Medical Research Command (NMRC) conduct bacteriophage therapy research to combat multidrug resistant bacteria that could impact warfighter readiness. Phages are viruses that target and kill antibiotic-resistant bacteria. Navy Medicine Research & Development (NMR&D) is engaged in bacteriophage therapy research to protect the warfighter from these threats, keeping U.S. forces ready and lethal. NMRC, headquarters of NMR&D, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Elliott Page /Released)
| Date Taken: | 04.11.2025 |
| Date Posted: | 06.06.2025 15:19 |
| Photo ID: | 9089719 |
| VIRIN: | 250411-N-EP096-1017 |
| Resolution: | 1086x724 |
| Size: | 163.42 KB |
| Location: | FREDERICK, MARYLAND, US |
| Web Views: | 0 |
| Downloads: | 1 |
This work, NMR&D Reaches Milestones in Six Year CDRMP Focused Program Award for Bacteriophage Therapy [Image 23 of 23], by Elliott Page, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
NMR&D Reaches Milestones in Six Year CDRMP Focused Program Award for Bacteriophage Therapy
No keywords found.
